Status:
COMPLETED
Regulation of Immunological Cytokines by Qiliqiangxin Capsule in Dilated Cardiomyopathy Patients
Lead Sponsor:
Harbin Medical University
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
18-70 years
Brief Summary
Purpose :Research into the impact of Qiliqiangxin capsule on IFN-γ，IL-4，NT-proBNP in dilated cardiomyopathy patients with heart failure. Methods :Data were collected from the patients with idiopathic...
Eligibility Criteria
Inclusion
- Congetive heart failure
Exclusion
- Valvular heart diseases
Key Trial Info
Start Date :
May 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02283450
Start Date
May 1 2012
End Date
April 1 2014
Last Update
November 5 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.